Coassociation between group b streptococcus and candida albicans promotes interactions with vaginal epithelium

Infection and Immunity

Volumn 86, Issue 4, 2018, Pages

  Pidwill, Grace R ^a   Rego, Sara ^a,c   Jenkinson, Howard F ^a   Lamont, Richard J ^b   Nobbs, Angela H ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesins; Candida albicans; Cocolonization; Polymicrobial interactions; Streptococcus agalactiae; Vaginal epithelium

Indexed keywords

ADHESIN; ADHESIN ALS; BACTERIAL PROTEIN; FUNGAL PROTEIN; POLYPEPTIDE; UNCLASSIFIED DRUG; ALS3 PROTEIN, CANDIDA ALBICANS;

ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; EPITHELIAL CELL LINE; FUNGUS HYPHAE; LACTOCOCCUS LACTIS; NONHUMAN; ORGANISMAL INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS AGALACTIAE; TROPISM; VAGINA EPITHELIUM; CANDIDIASIS; CLASSIFICATION; EPITHELIUM CELL; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MIXED INFECTION; MUCOSA; MUTATION; STREPTOCOCCUS INFECTION; VAGINA;

ADHESINS, BACTERIAL; CANDIDA ALBICANS; CANDIDIASIS; COINFECTION; EPITHELIAL CELLS; FEMALE; FUNGAL PROTEINS; HUMANS; MICROBIAL INTERACTIONS; MUCOUS MEMBRANE; MUTATION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA;

EID: 85044313764     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00669-17     Document Type: Article

References (58)

1. Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Heath PT. 2012. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 379: 547-556. https://doi.org/10.1016/S0140-6736(11)61651-6.
2. Le Doare K, Heath PT. 2013. An overview of global GBS epidemiology. Vaccine 31(Suppl 4):D7-D12. https://doi.org/10.1016/j.vaccine.2013.01.009.
3. Farley MM. 2001. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 33:556-561. https://doi.org/10.1086/322696.
4. Hughes R, Brocklehurst P, Heath P, Stenson B, Royal College of Obstetricians and Gynaecologists. 2017. Prevention of early-onset neonatal group B streptococcal disease: green-top guideline no. 36.BJOG 124: e280-e305. https://doi.org/10.1111/1471-0528.14821.
5. Sheen TR, Jimenez A, Wang NY, Banerjee A, van Sorge NM, Doran KS. 2011. Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J Bacteriol 193:6834-6842. https:// doi.org/10.1128/JB.00094-11.
6. Bolduc GR, Baron MJ, Gravekamp C, Lachenauer CS, Madoff LC. 2002. The alpha C protein mediates internalization of group B Streptococcus within human cervical epithelial cells. Cell Microbiol 4:751-758. https:// doi.org/10.1046/j.1462-5822.2002.00227.x.
7. Santi I, Scarselli M, Mariani M, Pezzicoli A, Masignani V, Taddei A, Grandi G, Telford JL, Soriani M. 2007. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood. Mol Microbiol 63:754-767. https://doi.org/10.1111/j.1365-2958.2006 .05555.x.
8. Seo HS, Mu R, Kim BJ, Doran KS, Sullam PM. 2012. Binding of glycoprotein Srr1 of Streptococcus agalactiae to fibrinogen promotes attachment to brain endothelium and the development of meningitis. PLoS Pathog 8:e1002947. https://doi.org/10.1371/journal.ppat.1002947.
9. Schubert A, Zakikhany K, Pietrocola G, Meinke A, Speziale P, Eikmanns BJ, Reinscheid DJ. 2004. The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells. Infect Immun 72:6197-6205. https://doi.org/10.1128/IAI.72.11.6197-6205.2004.
10. Spellerberg B, Rozdzinski E, Martin S, Weber-Heynemann J, Schnitzler N, Lutticken R, Podbielski A. 1999. Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin. Infect Immun 67:871-878.
11. Chuzeville S, Dramsi S, Madec JY, Haenni M, Payot S. 2015. Antigen I/II encoded by integrative and conjugative elements of Streptococcus agalactiae and role in biofilm formation. Microb Pathog 88:1-9. https://doi .org/10.1016/j.micpath.2015.07.018.
12. Rego S, Heal TJ, Pidwill GR, Till M, Robson A, Lamont RJ, Sessions RB, Jenkinson HF, Race PR, Nobbs AH. 2016. Structural and functional analysis of cell wall-anchored polypeptide adhesin BspA in Streptococcus agalactiae. J Biol Chem 291:15985-16000. https://doi.org/10.1074/jbc .M116.726562.
13. van de Wijgert JH, Borgdorff H, Verhelst R, Crucitti T, Francis S, Verstraelen H, Jespers V. 2014. The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One 9:e105998. https://doi.org/10.1371/journal.pone.0105998.
14. Monif GR, Carson HJ. 1998. Female genital tract bacterial coisolates with Candida albicans in patients without clinical vaginitis. Infect Dis Obstet Gynecol 6:52-56.
15. Bayo M, Berlanga M, Agut M. 2002. Vaginal microbiota in healthy pregnant women and prenatal screening of group B streptococci (GBS). Int Microbiol 5:87-90. https://doi.org/10.1007/s10123-002-0064-1.
16. Meyn LA, Krohn MA, Hillier SL. 2009. Rectal colonization by group B Streptococcus as a predictor of vaginal colonization. Am J Obstet Gynecol 201:76.e1-76.e7. https://doi.org/10.1016/j.ajog.2009.02.011.
17. Cools P, Jespers V, Hardy L, Crucitti T, Delany-Moretlwe S, Mwaura M, Ndayisaba GF, van de Wijgert JH, Vaneechoutte M. 2016. A multi-country cross-sectional study of vaginal carriage of group B streptococci (GBS) and Escherichia coli in resource-poor settings: prevalences and risk factors. PLoS One 11:e0148052.18. https://doi.org/10.1371/journal.pone .0148052.
18. Cotch MF, Hillier SL, Gibbs RS, Eschenbach DA. 1998. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Am J Obstet Gynecol 178:374-380. https://doi.org/ 10.1016/S0002-9378(98)80028-8.
19. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309-317. https://doi.org/10.1086/421946.
20. Sobel JD. 2007. Vulvovaginal candidosis. Lancet 369:1961-1971. https:// doi.org/10.1016/S0140-6736(07)60917-9.
21. Li F, Palecek SP. 2003. EAP1, a Candida albicans gene involved in binding human epithelial cells. Eukaryot Cell 2:1266-1273. https://doi.org/10 .1128/EC.2.6.1266-1273.2003.
22. Hoyer LL, Payne TL, Bell M, Myers AM, Scherer S. 1998. Candida albicans ALS3 and insights into the nature of the ALS gene family. Curr Genet 33:451-459. https://doi.org/10.1007/s002940050359.
23. Ko HC, Hsiao TY, Chen CT, Yang YL. 2013. Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence. J Microbiol 51:345-351. https://doi.org/10.1007/s12275 -013-2577-z.
24. Citiulo F, Jacobsen ID, Miramon P, Schild L, Brunke S, Zipfel P, Brock M, Hube B, Wilson D. 2012. Candida albicans scavenges host zinc via Pra1 during endothelial invasion. PLoS Pathog 8:e1002777. https://doi.org/10 .1371/journal.ppat.1002777.
25. Villamon E, Gozalbo D, Martinez JP, Gil ML. 1999. Purification of a biologically active recombinant glyceraldehyde 3-phosphate dehydrogenase from Candida albicans. FEMS Microbiol Lett 179:61-65.
26. Staab JF, Bradway SD, Fidel PL, Sundstrom P. 1999. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283:1535-1538. https://doi.org/10.1126/science.283.5407 .1535.
27. Sun JN, Solis NV, Phan QT, Bajwa JS, Kashleva H, Thompson A, Liu Y, Dongari-Bagtzoglou A, Edgerton M, Filler SG. 2010. Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog 6:e1001181. https://doi.org/10.1371/journal.ppat.1001181.
28. Klaile E, Muller MM, Schafer MR, Clauder AK, Feer S, Heyl KA, Stock M, Klassert TE, Zipfel PF, Singer BB, Slevogt H. 2017. Binding of Candida albicans to human CEACAM1 and CEACAM6 modulates the inflammatory response of intestinal epithelial cells. mBio 8:e02142-16. https://doi .org/10.1128/mBio.02142-16.
29. Phan QT, Myers CL, Fu Y, Sheppard DC, Yeaman MR, Welch WH, Ibrahim AS, Edwards JE, Jr, Filler SG. 2007. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 5:e64. https://doi.org/10.1371/journal.pbio.0050064.
30. Bamford CV, d'Mello A, Nobbs AH, Dutton LC, Vickerman MM, Jenkinson HF. 2009. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect Immun 77: 3696-3704. https://doi.org/10.1128/IAI.00438-09.
31. Shirtliff ME, Peters BM, Jabra-Rizk MA. 2009. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett 299:1-8. https://doi .org/10.1111/j.1574-6968.2009.01668.x.
32. Silverman RJ, Nobbs AH, Vickerman MM, Barbour ME, Jenkinson HF. 2010. Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities. Infect Immun 78:4644-4652. https://doi.org/10.1128/IAI .00685-10.
33. Hwang G, Liu Y, Kim D, Li Y, Krysan DJ, Koo H. 2017. Candida albicans mannans mediate Streptococcus mutans exoenzyme GtfB binding to modulate cross-kingdom biofilm development in vivo. PLoS Pathog 13:e1006407. https://doi.org/10.1371/journal.ppat.1006407.
34. Diaz PI, Xie Z, Sobue T, Thompson A, Biyikoglu B, Ricker A, Ikonomou L, Dongari-Bagtzoglou A. 2012. Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model. Infect Immun 80:620-632. https://doi.org/10.1128/IAI.05896-11.
35. Xu H, Sobue T, Bertolini M, Thompson A, Dongari-Bagtzoglou A. 2016. Streptococcus oralis and Candida albicans synergistically activate μ-calpain to degrade E-cadherin from oral epithelial junctions. J Infect Dis 214:925-934. https://doi.org/10.1093/infdis/jiw201.
36. Schlecht LM, Peters BM, Krom BP, Freiberg JA, Hansch GM, Filler SG, Jabra-Rizk MA, Shirtliff ME. 2015. Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue. Microbiology 161:168-181. https://doi.org/10.1099/mic.0.083485-0.
37. Peters BM, Ovchinnikova ES, Krom BP, Schlecht LM, Zhou H, Hoyer LL, Busscher HJ, van der Mei HC, Jabra-Rizk MA, Shirtliff ME. 2012. Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p. Microbiology 158:2975-2986. https://doi.org/ 10.1099/mic.0.062109-0.
38. Zhang Y, Lei Y, Nobbs A, Khammanivong A, Herzberg MC. 2005. Inactivation of Streptococcus gordonii SspAB alters expression of multiple adhesin genes. Infect Immun 73:3351-3357. https://doi.org/10.1128/IAI .73.6.3351-3357.2005.
39. Zhao X, Oh SH, Cheng G, Green CB, Nuessen JA, Yeater K, Leng RP, Brown AJ, Hoyer LL. 2004. ALS3 and ALS8 represent a single locus that encodes a Candida albicans adhesin; functional comparisons between Als3p and Als1p. Microbiology 150:2415-2428. https://doi.org/10.1099/ mic.0.26943-0.
40. Nobbs AH, Vickerman MM, Jenkinson HF. 2010. Heterologous expression of Candida albicans cell wall-associated adhesins in Saccharomyces cerevisiae reveals differential specificities in adherence and biofilm formation and in binding oral Streptococcus gordonii. Eukaryot Cell 9:1622-1634. https://doi.org/10.1128/EC.00103-10.
41. NIH. 20 December 2002. Research on microbial biofilms. PA number PA-03-047. https://grants.nih.gov/grants/guide/pa-files/PA-03-047.html.
42. Kim D, Sengupta A, Niepa TH, Lee BH, Weljie A, Freitas-Blanco VS, Murata RM, Stebe KJ, Lee D, Koo H. 2017. Candida albicans stimulates Streptococcus mutans microcolony development via cross-kingdom biofilm-derived metabolites. Sci Rep 7:41332. https://doi.org/10.1038/srep41332.
43. Uppuluri P, Busscher HJ, Chakladar J, van der Mei HC, Chaffin WL. 2017. Transcriptional profiling of C. albicans in a two species biofilm with Rothia dentocariosa. Front Cell Infect Microbiol 7:311. https://doi.org/10 .3389/fcimb.2017.00311.
44. Hoyer LL, Oh SH, Jones R, Cota E. 2014. A proposed mechanism for the interaction between the Candida albicans Als3 adhesin and streptococcal cell wall proteins. Front Microbiol 5:564. https://doi.org/10.3389/ fmicb.2014.00564.
45. Maddocks SE, Wright CJ, Nobbs AH, Brittan JL, Franklin L, Stromberg N, Kadioglu A, Jepson MA, Jenkinson HF. 2011. Streptococcus pyogenes antigen I/II-family polypeptide AspA shows differential ligand-binding properties and mediates biofilm formation. Mol Microbiol 81: 1034-1049. https://doi.org/10.1111/j.1365-2958.2011.07749.x.
46. Troffer-Charlier N, Ogier J, Moras D, Cavarelli J. 2002. Crystal structure of the V-region of Streptococcus mutans antigen I/II at 2.4 Å resolution suggests a sugar preformed binding site. J Mol Biol 318:179-188. https://doi.org/10.1016/S0022-2836(02)00025-6.
47. Forsgren N, Lamont RJ, Persson K. 2009. Crystal structure of the variable domain of the Streptococcus gordonii surface protein SspB. Protein Sci 18:1896-1905. https://doi.org/10.1002/pro.200.
48. Yeaman MR, Filler SG, Schmidt CS, Ibrahim AS, Edwards JE, Jr, Hennessey JP, Jr. 2014. Applying convergent immunity to innovative vaccines targeting Staphylococcus aureus. Front Immunol 5:463. https://doi.org/ 10.3389/fimmu.2014.00463.
49. Schrag SJ, Verani JR. 2013. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine 31:D20-D26. https://doi.org/10.1016/j.vaccine.2012.11.056.
50. Luthander J, Bennet R, Giske CG, Nilsson A, Eriksson M. 2015. The aetiology of paediatric bloodstream infections changes after pneumococcal vaccination and group B Streptococcus prophylaxis. Acta Paediatr 104:933-939. https://doi.org/10.1111/apa.13070.
51. Schmidt CS, White CJ, Ibrahim AS, Filler SG, Fu Y, Yeaman MR, Edwards JE, Jr, Hennessey JP, Jr. 2012. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine 30:7594-7600. https://doi.org/10.1016/j.vaccine.2012.10 .038.
52. Maisey HC, Hensler M, Nizet V, Doran KS. 2007. Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol 189:1464-1467. https://doi.org/10 .1128/JB.01153-06.
53. Pritzlaff CA, Chang JC, Kuo SP, Tamura GS, Rubens CE, Nizet V. 2001. Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus. Mol Microbiol 39:236-247. https://doi.org/10.1046/j.1365-2958 .2001.02211.x.
54. Hirt H, Erlandsen SL, Dunny GM. 2000. Heterologous inducible expression of Enterococcus faecalis pCF10 aggregation substance asc10 in Lactococcus lactis and Streptococcus gordonii contributes to cell hydrophobicity and adhesion to fibrin. J Bacteriol 182:2299-2306. https://doi .org/10.1128/JB.182.8.2299-2306.2000.
55. Fichorova RN, Yamamoto HS, Delaney ML, Onderdonk AB, Doncel GF. 2011. Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. mBio 2:e00168-11. https:// doi.org/10.1128/mBio.00168-11.
56. Steele C, Fidel JPL. 2002. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 70:577-583. https://doi.org/10.1128/IAI.70.2.577-583.2002.
57. Dutton LC, Nobbs AH, Jepson K, Jepson MA, Vickerman MM, Aqeel Alawfi S, Munro CA, Lamont RJ, Jenkinson HF. 2014. O-mannosylation in Candida albicans enables development of interkingdom biofilm communities. mBio 5:e00911-14. https://doi.org/10.1128/mBio.00911-14.
58. Claverys JP, Dintilhac A, Pestova EV, Martin B, Morrison DA. 1995. Construction and evaluation of new drug-resistance cassettes for gene disruption mutagenesis in Streptococcus pneumoniae, using an ami test platform. Gene 164:123-128. https://doi.org/10.1016/0378-1119(95)00485-O.